Breaking News

Thursday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	Boston Scientific management to meet virtually with BTIG » 04:55 05/19/22 05/19 04:55 05/19/22 04:55 BSX Boston Scientific $40.22 / -1.09 (-2.64%) Medical Technology and… Medical Technology and Digital Health Analyst Thibault holds a virtual meeting with management on May 19 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $40.22 / -1.09 (-2.64%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System BSX Boston Scientific $40.22 / -1.09 (-2.64%) 05/17/22 Citi Boston Scientific price target lowered to $47 from $52 at Citi 05/16/22 Morgan Stanley Boston Scientific named a 'Top Pick' at Morgan Stanley after meeting with CEO 05/03/22 Piper Sandler Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own' 04/27/22 Piper Sandler Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler BSX Boston Scientific $40.22 / -1.09 (-2.64%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $40.22 / -1.09 (-2.64%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $40.22 / -1.09 (-2.64%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 09/07/22 2022 Wells Fargo Healthcare Conference 05/19/22 Boston Scientific BSX Boston Scientific $40.22 / -1.09 (-2.64%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish

Over a week ago
Recommendations	Boston Scientific price target lowered to $47 from $52 at Citi » 06:24 05/17/22 05/17 06:24 05/17/22 06:24 BSX Boston Scientific $39.83 / +0.175 (+0.44%) Citi analyst Joanne… Citi analyst Joanne Wuensch lowered the firm's price target on Boston Scientific to $47 from $52 and keeps a Buy rating on the shares. Market multiples are contracting due to higher inflation, slowing growth, and rising interest rates, Wuensch tells investors in a research note. What we don't know yet is how far the derating will go and where does medical technology shake out, balancing an elective procedure recovery with macro headwinds, says the analyst. "When is the right time to catch a falling knife? If recent history is any suggestion, the answer could be 'soon,'" writes Wuensch. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $39.83 / +0.175 (+0.44%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System BSX Boston Scientific $39.83 / +0.175 (+0.44%) 05/16/22 Morgan Stanley Boston Scientific named a 'Top Pick' at Morgan Stanley after meeting with CEO 05/03/22 Piper Sandler Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own' 04/27/22 Piper Sandler Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results BSX Boston Scientific $39.83 / +0.175 (+0.44%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $39.83 / +0.175 (+0.44%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $39.83 / +0.175 (+0.44%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 09/07/22 2022 Wells Fargo Healthcare Conference 05/19/22 Boston Scientific BSX Boston Scientific $39.83 / +0.175 (+0.44%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish
Recommendations	Boston Scientific named a 'Top Pick' at Morgan Stanley after meeting with CEO » 06:44 05/16/22 05/16 06:44 05/16/22 06:44 BSX Boston Scientific $39.65 / +0.87 (+2.24%) Morgan Stanley analyst… Morgan Stanley analyst Cecilia Furlong noted that she recently spent an hour with Boston Scientific's CEO Mike Mahoney, after which she named the stock her "Top Pick" as the conversation left her with increased confidence in Boston's ability to hit near-term targets with growth drivers beyond. Boston Scientific's recent analyst day reaffirmed above-peer growth targets and double-digit EPS growth for the foreseeable future, noted Furlong, who has an Overweight rating and $51 price target on the shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $39.65 / +0.87 (+2.24%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System BSX Boston Scientific $39.65 / +0.87 (+2.24%) 05/03/22 Piper Sandler Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own' 04/27/22 Piper Sandler Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others BSX Boston Scientific $39.65 / +0.87 (+2.24%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $39.65 / +0.87 (+2.24%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $39.65 / +0.87 (+2.24%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 09/07/22 2022 Wells Fargo Healthcare Conference 05/19/22 Boston Scientific BSX Boston Scientific $39.65 / +0.87 (+2.24%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish
Earnings	Prometheus reports Q1 EPS (82c), consensus (79c) » 16:07 05/12/22 05/12 16:07 05/12/22 16:07 RXDX Prometheus $23.36 / +1.05 (+4.71%) "I couldn't be… "I couldn't be more pleased with the execution our team has demonstrated during a very challenging external backdrop. Despite significant global headwinds and our aggressive timelines, we are still on track to deliver on our near-term milestones, namely the topline results from our Artemis-UC Phase 2 and Apollo-CD Phase 2a trials in the fourth quarter this year," said Mark McKenna, Chairman and CEO. Upcoming milestone vents: Update on UC and CD Phase 2 enrollment planned in 2Q; IND submission for PR600 planned for 3Q; Topline results from the ARTEMIS-UC Phase 2 study expected in 4Q; Topline results from APOLLO-CD Phase 2a study expected in 4Q. ShowHide Related Items >><< Company News Street Research Earnings Events RXDX Prometheus $23.36 / +1.05 (+4.71%) 03/30/22 Prometheus initates third Phase 2 study of PRA023 for SSc-ILD 01/12/22 Prometheus provides corporate updates at JP Morgan Healthcare Conference 01/03/22 Prometheus, Dr. Falk Pharma advance PR600, trigger final preclinical milestone 12/07/21 Prometheus reports positive results from Phase 1 trial of PRA023 RXDX Prometheus $23.36 / +1.05 (+4.71%) 03/10/22 Wells Fargo Prometheus price target raised to $53 from $42 at Wells Fargo 02/11/22 BTIG Prometheus initiated with a Buy at BTIG 02/11/22 BTIG Prometheus initiated with a Buy at BTIG 12/13/21 RBC Capital Prometheus initiated with an Outperform at RBC Capital RXDX Prometheus $23.36 / +1.05 (+4.71%) 03/09/22 Prometheus reports Q4 EPS (77c), consensus (68c) 05/22/22 DDW 2022 05/19/22 Prometheus Biosciences, Inc.
Conference/Events	Boston Scientific management to meet virtually with BTIG » 12:57 05/12/22 05/12 12:57 05/12/22 12:57 BSX Boston Scientific $38.61 / -0.14 (-0.36%) Medical Technology and… Medical Technology and Digital Health Analyst Thibault holds a virtual meeting with management on May 19 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $38.61 / -0.14 (-0.36%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System BSX Boston Scientific $38.61 / -0.14 (-0.36%) 05/03/22 Piper Sandler Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own' 04/27/22 Piper Sandler Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others BSX Boston Scientific $38.61 / -0.14 (-0.36%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $38.61 / -0.14 (-0.36%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $38.61 / -0.14 (-0.36%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 05/10/22 Healthcare Conference 05/13/22 AUA 2022 09/07/22 2022 Wells Fargo Healthcare Conference 05/19/22 Boston Scientific BSX Boston Scientific $38.61 / -0.14 (-0.36%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish

Recommendations	Piper raises Zimmer Biomet target to $130, but sees 'better large caps to own' » 13:44 05/03/22 05/03 13:44 05/03/22 13:44 ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) , BSX Boston Scientific $41.93 / +0.31 (+0.74%) , DXCM DexCom $398.54 / -8.42 (-2.07%) , SYK Stryker $238.31 / +1.49 (+0.63%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien raised the firm's price target on Zimmer Biomet (ZBH) to $130 from $110 and keeps a Neutral rating on the shares after the company reported Q1 results that beat "modest expectations" and raised guidance from what he calls "a very soft initial view on the year." While he believes the backlog of orthopedic cases starting to filter through the system is a positive and notes that the inflationary effect on Zimmer Biomet is not as negative as he feared, O'Brien continues to see more attractive growth names across the large cap med tech universe that he continues to favor, such as Boston Scientific (BSX), DexCom (DXCM) and Stryker (SYK). ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZBH SYK DXCM BSX ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) 03/24/22 Assure Holdings appoints Kelly Shelton as VP, sales, Sherri Wagner as VP, HR 03/02/22 ZimVie to replace Tabula Rasa HealthCare in S&P 600 at open on 3/2 03/01/22 ZimVie completes separation from Zimmer Biomet SYK Stryker $238.31 / +1.49 (+0.63%) 04/11/22 Stryker says CMS grants outpatient facility code for InSpace implant 04/06/22 Spruce Point names Stryker as short target, sees 35%-75% downside risk 04/06/22 Stryker falls 5% to $254 after Spruce Point short report 03/07/22 Stryker sees Q1 EPS 'deleveraged' from operating expense standpoint DXCM DexCom $398.54 / -8.42 (-2.07%) 04/01/22 DexCom to launch Dexcom One Continuous Glucose Monitoring System in UK 03/25/22 DexCom announces four-for-one forward stock split 03/14/22 DexCom announces CE Mark for G7 Continuous Glucose Monitoring System 03/07/22 DexCom: Ontario government to provide coverage for Dexcom G6 CGM System BSX Boston Scientific $41.93 / +0.31 (+0.74%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System ZBH BSX DXCM SYK ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Zimmer Biomet assumed at Hold from Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned BSX Boston Scientific $41.93 / +0.31 (+0.74%) 04/27/22 Piper Sandler Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler 04/12/22 Truist Boston Scientific assumed with a Buy at Truist DXCM DexCom $398.54 / -8.42 (-2.07%) 04/29/22 SVB Leerink DexCom price target lowered to $500 from $565 at SVB Leerink 04/29/22 Canaccord DexCom price target lowered to $500 from $525 at Canaccord 04/29/22 Raymond James DexCom price target lowered to $486 from $538 at Raymond James 04/29/22 Piper Sandler DexCom price target lowered to $480 from $725 at Piper Sandler SYK Stryker $238.31 / +1.49 (+0.63%) 05/02/22 Truist Stryker price target lowered to $280 from $296 at Truist 04/29/22 Piper Sandler Stryker price target lowered to $290 from $315 at Piper Sandler 04/19/22 BTIG J&J results will be viewed favorably for MedTech group, says BTIG ZBH SYK DXCM BSX ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) 02/07/22 Zimmer Biomet's ZimVie spin off sees FY22 adjusted EPS $2.10-$2.30 02/07/22 Zimmer Biomet sees FY22 adjusted EPS $6.40-$6.80, consensus $7.92 02/07/22 Zimmer Biomet reports Q4 EPS $1.95, consensus $1.98 11/05/21 Zimmer Biomet lowers FY21 EPS view to $7.32-$7.47 from $7.65-$7.95 SYK Stryker $238.31 / +1.49 (+0.63%) 04/28/22 Stryker sees FY22 EPS at lower end of $9.60-$10.00 range, consensus $9.76 04/28/22 Stryker reports Q1 EPS $1.97, consensus $1.95 04/28/22 Notable companies reporting after market close 03/07/22 Stryker still sees FY22 EPS $9.60-$10.00, consensus $9.79 DXCM DexCom $398.54 / -8.42 (-2.07%) 04/28/22 DexCom reports Q1 EPS 93c, consensus 52c 02/10/22 DexCom sees FY22 revenue $2.82B-$2.94B, consensus $2.96B 02/10/22 DexCom reports Q4 EPS 68c, consensus 85c 02/10/22 Notable companies reporting after market close BSX Boston Scientific $41.93 / +0.31 (+0.74%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open SYK BSX SYK Stryker $238.31 / +1.49 (+0.63%) 04/06/22 Spruce Point sees 35%-75% downside risk in Stryker shares 04/06/22 Spruce Point announces short position in Stryker with 'Strong Sell' rating BSX Boston Scientific $41.93 / +0.31 (+0.74%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports ZBH SYK DXCM BSX ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) 03/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/07/22 Wall Street in Fives - Must Read Lists for Monday 02/07/22 Wall Street in Fives - Must Read Lists at Midday 02/07/22 Fly Intel: Pre-market Movers SYK Stryker $238.31 / +1.49 (+0.63%) 04/06/22 What You Missed On Wall Street On Wednesday 04/06/22 What You Missed On Wall Street This Morning 03/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/27/22 Fly Intel: After-Hours Movers DXCM DexCom $398.54 / -8.42 (-2.07%) 02/11/22 Wall Street in Fives - Must Read Lists for Friday 02/11/22 Wall Street in Fives - Must Read Lists at Midday 02/10/22 Fly Intel: After-Hours Movers 02/03/22 Wall Street in Fives - Must Read Lists for Thursday BSX Boston Scientific $41.93 / +0.31 (+0.74%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 05/06/22 ESTRO 2022 00:00 Today MedTech, Tools & Diagnostics Virtual Summit 05/31/22 2022 Wells Fargo West Coast MedTech Tour 09/07/22 2022 Wells Fargo Healthcare Conference 05/03/22 Zimmer Biomet - ZBH 05/04/22 Stryker Corp. 05/05/22 Boston Scientific Corporation 05/13/22 Zimmer Biomet Holdings, Inc. 05/19/22 Boston Scientific 05/19/22 DexCom, Inc. ZBH SYK DXCM BSX ZBH Zimmer Biomet $122.68 / +1.98 (+1.64%) 03/02/22 new option listings and two option delistings on March 2nd 03/01/22 Two option delistings on March 1st SYK Stryker $238.31 / +1.49 (+0.63%) 04/19/22 Early notable gainers among liquid option names on April 19th DXCM DexCom $398.54 / -8.42 (-2.07%) 04/01/22 Early notable gainers among liquid option names on April 1st 03/25/22 Early notable gainers among liquid option names on March 25th 02/22/22 Early notable gainers among liquid option names on February 22nd 01/20/22 Early notable gainers among liquid option names on January 20th BSX Boston Scientific $41.93 / +0.31 (+0.74%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish
Recommendations	Boston Scientific beat and modest raise 'a welcome sight,' says Piper Sandler » 14:56 04/27/22 04/27 14:56 04/27/22 14:56 BSX Boston Scientific $43.61 / +0.97 (+2.27%) Piper Sandler analyst… Piper Sandler analyst Matt O'Brien notes Boston Scientific reported Q1 results with both sales and EPS coming in ahead of expectations. Management raised guidance slightly on the top- and bottom-lines, the latter of which was a welcome update given all the inflationary pressures the company and Med Tech is experiencing, the analyst contends. O'Brien adds that gross margins will be under pressure for the year but some of these headwinds should abate late in the year and into 2023, setting the company up to be a strong grower and margin expansion story as well. With many of the key growth drivers intact there is a lot to like about the name, the analyst says. O'Brien reiterates an Overweight rating on the shares with a price target of $50. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $43.61 / +0.97 (+2.27%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System 11/01/21 Nevro announces update in Boston Scientific patent litigation, to pay $20M BSX Boston Scientific $43.61 / +0.97 (+2.27%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Boston Scientific assumed with a Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned BSX Boston Scientific $43.61 / +0.97 (+2.27%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $43.61 / +0.97 (+2.27%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $43.61 / +0.97 (+2.27%) 04/27/22 Fly Intel: Pre-market Movers 02/02/22 Fly Intel: Pre-market Movers 04/27/22 Boston Scientific - BSX 05/05/22 Boston Scientific Corporation 05/19/22 Boston Scientific BSX Boston Scientific $43.61 / +0.97 (+2.27%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish
On The Fly	Fly Intel: Pre-market Movers » 09:15 04/27/22 04/27 09:15 04/27/22 09:15 MAT Mattel $22.14 / -1.055 (-4.55%) , TMUS T-Mobile $124.90 / -3.96 (-3.07%) , GD General Dynamics $237.06 / -2 (-0.84%) , BSX Boston Scientific $42.63 / -1.955 (-4.38%) , NEO NeoGenomics $10.83 / -0.45 (-3.99%) , V Visa $201.21 / -9.03 (-4.30%) , MSFT Microsoft $270.08 / -10.79 (-3.84%) , BA Boeing $166.91 / -8.84 (-5.03%) , HOG Harley-Davidson $36.50 / -1.77 (-4.63%) , NCR NCR Corp. $37.26 / -2.74 (-6.85%) , GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) , HOOD Robinhood $10.00 / -0.405 (-3.89%) Check out this morning's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options V TMUS NEO NCR MSFT MAT HOOD HOG GOOGL GD BSX BA V Visa $201.21 / -9.03 (-4.30%) 04/26/22 Visa reports Q2 payments volume up 17% y/y 04/26/22 Caesars, Bread Financial partner for new Caesars Rewards Visa card 04/05/22 Visa, PopID announce facial verification payment acceptance partnership 03/31/22 Chase enters multi-year extension with Amazon for Prime Rewards Visa credit card TMUS T-Mobile $124.90 / -3.96 (-3.07%) 04/27/22 T-Mobile 'somewhat insulated' from inflation, says CEO Sievert 04/27/22 T-Mobile raises FY22 adjusted EBITDA view to $25.8B-$26.2B from $25.6B-$26.1B 04/27/22 T-Mobile reports Q1 postpaid churn 0.93% vs. 0.98% y/y 04/27/22 T-Mobile reports Q1 postpaid net account additions 348K NEO NeoGenomics $10.83 / -0.45 (-3.99%) 04/27/22 NeoGenomics says 'on track to overcome' current challenges 04/11/22 NeoGenomics expands strategic partnership initiatives with Biognosys 04/11/22 NeoGenomics expands partnership with Biognosys 03/28/22 NeoGenomics trading resumes NCR NCR Corp. $37.26 / -2.74 (-6.85%) 04/26/22 NCR Corp. drops 16% to $31.25 after lowering FY22 guidance 03/29/22 Bandwidth appoints Sandy Preizler as Chief Revenue Officer 03/08/22 NCR Corp. suspends sales of all products in Russia 03/08/22 NCR acquires fintech intellectual property for Open Banking from Spoke MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/26/22 Microsoft says Xbox was top seller in quarter in U.S., U.K., Western Europe 04/26/22 Microsoft says 'record' Q3 quarter driven by Cloud 04/26/22 Microsoft reports Q3 LinkedIn revenue up 34%, Intelligent Cloud revenue $19.1B 04/26/22 Microsoft to provide forward-looking guidance on earnings call MAT Mattel $22.14 / -1.055 (-4.55%) 04/26/22 Mattel jumps 12.9% to $24.96 after WSJ report about sale discussions with PE 04/05/22 Mattel appoints Steve Totzke as president 03/29/22 Mattel announces licensing agreement with Universal for Trolls franchise 02/09/22 Mattel jumps 10% to $25.05 after Q4 results, FY22 guidance beat estimates HOOD Robinhood $10.00 / -0.405 (-3.89%) 04/26/22 Robinhood CEO says cutting 9% of full-time staff, financial position 'strong' 04/26/22 Robinhood letting go approximately 9% of full-time employees 04/19/22 Robinhood acquires cryptoasset company Ziglu, terms not disclosed 04/07/22 Robinhood to add ability to transact on Bitcoin Lightning Network HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 04/27/22 Harley-Davidson reaffirms FY22 guidance 03/01/22 Harley-Davidson suspends all shipments to Russia 02/08/22 Harley-Davidson says moving to global vs. U.S. pricing mechanism in 2022 02/08/22 Harley-Davidson raises quarterly dividend to 15.75c from 15c per share GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/27/22 UiPath appoints Robert Enslin as co-CEO 04/26/22 Alphabet expects meaningful increase in capital expenditures in FY22 04/26/22 Alphabet Class A shares down 6% after Q1 earnings report 04/26/22 Alphabet authorizes repurchase of up to added $70B of shares GD General Dynamics $237.06 / -2 (-0.84%) 04/27/22 General Dynamics reports Q1 backlog $87.2B 04/27/22 General Dynamics reports Q1 cash from operations $2B 03/18/22 GDIT awarded $4.5B user facing and data center services contract by NGA 03/02/22 General Dynamics raises quarterly dividend to $1.26 from $1.19 per share BSX Boston Scientific $42.63 / -1.955 (-4.38%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System 11/01/21 Nevro announces update in Boston Scientific patent litigation, to pay $20M BA Boeing $166.91 / -8.84 (-5.03%) 04/27/22 Boeing continues to see passenger traffic returning to 2019 levels in 2023-2024 04/27/22 Boeing reports Q1 commercial airplane deliveries of 95 vs. 77 a year ago 04/27/22 Boeing CEO says 'on track to generate positive cash flow for 2022' 04/27/22 Boeing says 737 production and deliveries continue to increase MAT TMUS GD BSX NEO V MSFT BA HOG NCR GOOGL HOOD MAT Mattel $22.14 / -1.055 (-4.55%) 02/24/22 JPMorgan Mattel shares 'remain cheap' at current levels, says JPMorgan 02/24/22 Stifel Mattel upgraded to Buy from Hold at Stifel 02/14/22 DA Davidson Mattel price target raised to $45 from $38 at DA Davidson 02/10/22 Monness Crespi Mattel price target raised to $32 from $28 at Monness Crespi TMUS T-Mobile $124.90 / -3.96 (-3.07%) 03/23/22 KeyBanc KeyBanc upgrades T-Mobile to Overweight with $155 price target 03/23/22 KeyBanc T-Mobile upgraded to Overweight from Sector Weight at KeyBanc 03/14/22 Citi T-Mobile price target raised to $156 from $155 at Citi 03/11/22 Tigress Financial T-Mobile initiated with a Buy at Tigress Financial GD General Dynamics $237.06 / -2 (-0.84%) 03/29/22 Jefferies Northrop among biggest beneficiaries of DoD budget request, says Jefferies 03/07/22 Wells Fargo General Dynamics price target raised to $282 from $235 at Wells Fargo 02/04/22 Morgan Stanley Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook 02/04/22 Morgan Stanley General Dynamics upgraded to Equal Weight from Underweight at Morgan Stanley BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Boston Scientific assumed with a Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned NEO NeoGenomics $10.83 / -0.45 (-3.99%) 03/29/22 Cowen NeoGenomics price target lowered to $24 from $42 at Cowen 03/29/22 BTIG NeoGenomics price target lowered to $28 from $35 at BTIG 03/29/22 SVB Leerink NeoGenomics price target lowered to $20 from $45 at SVB Leerink 03/29/22 Needham NeoGenomics price target lowered to $19 from $29 at Needham V Visa $201.21 / -9.03 (-4.30%) 04/27/22 Cowen Visa price target lowered to $254 from $276 at Cowen 04/27/22 Morgan Stanley Visa price target raised to $284 from $279 at Morgan Stanley 04/27/22 Credit Suisse Visa price target raised to $265 from $260 at Credit Suisse 04/25/22 Citi Visa price target lowered to $265 from $285 at Citi MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/27/22 Morgan Stanley Morgan Stanley buyers of Microsoft after Q3 results, 'robust' guidance 04/27/22 Oppenheimer Microsoft Azure accelerates constant-currency growth to 49%, says Oppenheimer 04/27/22 Wedbush Microsoft price target lowered to $340 from $375 at Wedbush 04/27/22 Stifel Microsoft price target lowered to $350 from $380 at Stifel BA Boeing $166.91 / -8.84 (-5.03%) 04/22/22 Benchmark Boeing price target lowered to $250 from $270 at Benchmark 04/21/22 JPMorgan Boeing progress with 787 good news, says JPMorgan 04/08/22 Morgan Stanley Boeing price target lowered to $230 from $288 at Morgan Stanley 03/30/22 Jefferies China Southern's 3-year outlook from Boeing down 20 aircraft, says Jefferies HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 02/09/22 Baird Harley-Davidson price target raised to $60 from $50 at Baird 02/09/22 Morgan Stanley Harley-Davidson price target raised to $44 from $40 at Morgan Stanley 02/01/22 Morgan Stanley Harley-Davidson upgraded to Equal Weight from Underweight at Morgan Stanley 10/28/21 BMO Capital Harley-Davidson price target raised to $62 from $54 at BMO Capital NCR NCR Corp. $37.26 / -2.74 (-6.85%) 04/27/22 Morgan Stanley NCR Corp. price target lowered to $40 from $61 at Morgan Stanley 01/03/22 Stephens Wendy's, Kirby and Vizio among Stephens' 2022 Best Ideas 11/18/21 Stephens NCR Corp. initiated with an Overweight at Stephens 10/27/21 RBC Capital NCR Corp. price target lowered to $54 from $59 at RBC Capital GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/27/22 Guggenheim Alphabet price target lowered to $3,000 from $3,350 at Guggenheim 04/27/22 Jefferies Alphabet price target lowered to $3,400 from $3,600 at JefferiesAlphabet 04/27/22 Truist Alphabet price target lowered to $3,500 from $3,600 at Truist 04/27/22 Wells Fargo Alphabet price target lowered to $3,400 from $3,600 at Wells Fargo HOOD Robinhood $10.00 / -0.405 (-3.89%) 04/19/22 JMP Securities Ziglu deal should accelerate Robinhood's crypto expansion, says JMP Securities 04/08/22 Goldman Sachs Robinhood downgraded to Sell from Neutral at Goldman Sachs 04/07/22 Cowen Yellen remarks 'tacit support' for Gensler's crypto regulations, Cowen says 04/07/22 Deutsche Bank Robinhood price target lowered to $11 from $14 at Deutsche Bank V TMUS NEO NCR MSFT MAT HOOD HOG GOOGL GD BSX BA V Visa $201.21 / -9.03 (-4.30%) 04/26/22 Visa reports Q2 EPS $1.79, consensus $1.65 04/26/22 Notable companies reporting after market close 01/27/22 Visa reports Q1 EPS $1.81, consensus $1.70 01/27/22 Notable companies reporting after market close TMUS T-Mobile $124.90 / -3.96 (-3.07%) 04/27/22 T-Mobile reports Q1 EPS 57c, consensus 32c 04/26/22 Notable companies reporting before tomorrow's open 02/02/22 T-Mobile reports Q4 EPS 34c, consensus 18c NEO NeoGenomics $10.83 / -0.45 (-3.99%) 04/27/22 NeoGenomics reports Q1 adjusted EPS (20c), consensus (23c) 03/28/22 NeoGenomics now sees Q1 revenue below $118M-$120M range, consensus $119.16M NCR NCR Corp. $37.26 / -2.74 (-6.85%) 04/26/22 NCR Corp. lowers FY22 adjusted EPS view $2.70-$3.20 from $3.25-$3.55 04/26/22 NCR Corp. reports Q1 adjusted EPS 33c, consensus 63c 02/08/22 NCR Corp. sees FY22 adjusted EPS $3.25-$3.55, consensus $3.49 02/08/22 NCR Corp. sees Q1 adjusted EPS 60c-65c, consensus 72c MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 01/25/22 Microsoft reports Q2 EPS $2.48, consensus $2.31 MAT Mattel $22.14 / -1.055 (-4.55%) 02/09/22 Mattel updates FY23 goals, sees adjusted EPS above $1.90 02/09/22 Mattel sees FY22 adjusted EPS $1.42-$1.48, consensus $1.39 02/09/22 Mattel reports Q4 adjusted EPS 53c, consensus 30c 02/09/22 Notable companies reporting after market close HOOD Robinhood $10.00 / -0.405 (-3.89%) 01/27/22 Robinhood sees Q1 revenue less than $340M, consensus $448.19M 01/27/22 Robinhood reports Q4 EPS (49c), consensus (45c) HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 04/27/22 Harley-Davidson reports Q1 GAAP EPS $1.45, consensus $1.45 02/08/22 Harley-Davidson reports Q4 adjusted EPS 15c, consensus (37c) GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/26/22 Alphabet reports Q1 EPS $24.62, consensus $25.96 02/01/22 Alphabet reports Q4 EPS $30.69, consensus $27.32 02/01/22 Notable companies reporting after market close GD General Dynamics $237.06 / -2 (-0.84%) 04/27/22 General Dynamics reports Q1 EPS $2.61, consensus $2.51 01/26/22 General Dynamics sees FY22 EPS $12.00-$12.15, consensus $12.41 BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/27/22 Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c BA Boeing $166.91 / -8.84 (-5.03%) 04/27/22 Boeing reports Q1 core EPS ($2.75), consensus (12c) 04/11/22 Ultra Clean cuts Q1 revenue view to $560M-$570M from $580M-$630M 09 Sep 29 Jul V TMUS MSFT MAT HOOD HOG GOOGL GD BSX BA V Visa $201.21 / -9.03 (-4.30%) 04/22/22 Apple Cash switches networks to Visa from Discover, MacRumors says 04/07/22 Banks debate on bringing Zelle to checkout at big retailers, WSJ reports 04/01/22 Visa to update rules for gas stations to allow bigger purchases, Bloomberg says 04/01/22 Visa to update rules for gas stations to allow bigger purchases, Bloomberg says TMUS T-Mobile $124.90 / -3.96 (-3.07%) 04/13/22 T-Mobile bought customer data from hackers to try to stop leak, Vice reports 03/30/22 T-Mobile's shutdown of Sprint 3G network to start March 31, Verge says 01/30/22 T-Mobile to terminate unvaccinated corporate employees by April, Reuters says 01/11/22 Apple's Private Relay meets resistance by Europe carriers, 9to5Mac reports MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/26/22 Microsoft CFO tells Bloomberg Xbox hardware sales rose 14% in Q3 04/23/22 Apple is the last FAANG standing, Barron's says 04/22/22 NLRB rules that Activision's Raven Software can have union vote, WP says 04/22/22 Microsoft sells 13.87M Xbox Series X/S units in first 17 months, VGChartz says MAT Mattel $22.14 / -1.055 (-4.55%) 04/26/22 Mattel held talks with private equity names about potential sale, WSJ says 04/01/22 Mattel's top-selling toys to now be made in Mexico, Reuters reports 01/26/22 Mattel wins Disney toy deal license back from Hasbro, WSJ reports HOOD Robinhood $10.00 / -0.405 (-3.89%) 03/31/22 Robinhood near rollout of retirement accounts in app, Bloomberg says 03/31/22 Robinhood near rollout of retirement accounts in app, Bloomberg says 01/27/22 Court dismisses Robinhood 'meme stock' lawsuit, Reuters says 01/13/22 Robinhood must pay retail investor $30K for restricting trades, Verge says HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 10/31/21 U.S., EU end clash over steel and aluminum, Reuters reports GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/26/22 Tech giants tricked into giving out personal user data, Bloomberg says 04/23/22 EU sets new online rules for Google, Meta, Reuters reports 04/23/22 Execs say fix won't come fast for 'broken' Facebook, Barron's reports GD General Dynamics $237.06 / -2 (-0.84%) 04/19/22 Lockheed Martin in talks with Pentagon on weapons to Ukraine, WSJ reports 04/13/22 Defense contractors to meet with Pentagon to discuss Ukraine aid, FT reports 04/05/22 U.S., U.K. and Australia to co-operate on hypersonic weapons, FT says BSX Boston Scientific $42.63 / -1.955 (-4.38%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BA Boeing $166.91 / -8.84 (-5.03%) 04/22/22 Boeing may see added nine to 12-month delay in 777X program, Air Current says 04/22/22 American, United 787 deliveries delayed, causes setback, Bloomberg reports 04/20/22 Boeing telling airlines 787 deliveries to resume in second half, Reuters says 04/20/22 Boeing telling airlines 787 deliveries to resume in second half, Reuters says V TMUS NEO NCR MSFT MAT HOOD HOG GOOGL GD BSX BA V Visa $201.21 / -9.03 (-4.30%) 04/26/22 Fly Intel: After-Hours Movers 03/08/22 What You Missed On Wall Street On Tuesday 03/08/22 What You Missed On Wall Street This Morning 03/07/22 What You Missed On Wall Street On Monday TMUS T-Mobile $124.90 / -3.96 (-3.07%) 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning 03/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/22 Wall Street in Fives - Must Read Lists for Thursday NEO NeoGenomics $10.83 / -0.45 (-3.99%) 03/29/22 What You Missed On Wall Street On Tuesday 03/29/22 What You Missed On Wall Street This Morning 03/29/22 Fly Intel: Pre-market Movers 03/28/22 Fly Intel: After-Hours Movers NCR NCR Corp. $37.26 / -2.74 (-6.85%) 02/09/22 Wall Street in Fives - Must Read Lists for Wednesday 02/09/22 Wall Street in Fives - Must Read Lists at Midday 02/08/22 Fly Intel: After-Hours Movers MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/26/22 What Wall Street is saying about Alphabet ahead of earnings 04/26/22 What You Missed This Week in Video Games 04/26/22 What Wall Street is saying about Microsoft ahead of earnings MAT Mattel $22.14 / -1.055 (-4.55%) 02/10/22 Wall Street in Fives - Must Read Lists for Thursday 02/10/22 Wall Street in Fives - Must Read Lists at Midday 02/10/22 Fly Intel: Pre-market Movers 02/09/22 Fly Intel: After-Hours Movers HOOD Robinhood $10.00 / -0.405 (-3.89%) 04/22/22 Here's What You Missed in Crypto This Week 04/08/22 What You Missed On Wall Street On Friday 04/08/22 What You Missed On Wall Street This Morning HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 02/08/22 Wall Street in Fives - Must Read Lists for Tuesday 02/08/22 Wall Street in Fives - Must Read Lists at Midday 02/08/22 Fly Intel: Pre-market Movers 02/01/22 Wall Street in Fives - Must Read Lists for Tuesday GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/26/22 What You Missed On Wall Street On Tuesday 04/20/22 What You Missed On Wall Street On Wednesday GD General Dynamics $237.06 / -2 (-0.84%) 02/28/22 Fly Intel: Pre-market Movers 02/11/22 Wall Street in Fives - Must Read Lists for Friday 01/26/22 Wall Street in Fives - Must Read Lists for Wednesday 01/26/22 Wall Street in Fives - Must Read Lists at Midday BSX Boston Scientific $42.63 / -1.955 (-4.38%) 02/02/22 Fly Intel: Pre-market Movers BA Boeing $166.91 / -8.84 (-5.03%) 04/22/22 What You Missed On Wall Street On Friday 04/05/22 What You Missed On Wall Street This Morning 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning 04/27/22 Technology/Software 06/01/22 50th Annual Technology, Media & Telecom Conference 06/02/22 Healthcare Virtual Conference 04/27/22 Boston Scientific - BSX 04/27/22 T-Mobile - TMUS 04/27/22 NeoGenomics - NEO 04/27/22 Harley-Davidson - HOG 04/27/22 General Dynamics - GD 04/27/22 Boeing - BA 04/27/22 Mattel - MAT 04/28/22 Robinhood - HOOD 06/14/22 Microsoft - MSFT 04/29/22 Boeing Co. 05/02/22 NCR Corp 05/04/22 General Dynamics Corp 05/05/22 Boston Scientific Corporation 05/12/22 Harley-Davidson Inc. 05/19/22 Boston Scientific 16:00 Today Mattel Inc. 06/01/22 Alphabet Inc. CL A 06/02/22 NeoGenomics Inc. 06/06/22 Microsoft V TMUS NCR MSFT MAT HOOD HOG GOOGL BSX BA V Visa $201.21 / -9.03 (-4.30%) 04/26/22 Visa options imply 5.1% move in share price post-earnings 03/14/22 Visa call volume above normal and directionally bullish 02/03/22 Visa put volume heavy and directionally bearish 01/28/22 Early notable gainers among liquid option names on January 28th TMUS T-Mobile $124.90 / -3.96 (-3.07%) 02/03/22 Early notable gainers among liquid option names on February 3rd 01/24/22 T Mobile put volume heavy and directionally bearish 01/24/22 Early notable gainers among liquid option names on January 24th 12/14/21 Early notable gainers among liquid option names on December 14th NCR NCR Corp. $37.26 / -2.74 (-6.85%) 04/26/22 NCR Corp. options imply 8.0% move in share price post-earnings 04/08/22 NCR Corp. call buyer realizes 30% same-day gains MSFT Microsoft $270.08 / -10.79 (-3.84%) 04/27/22 Notable open interest changes for April 27th 04/26/22 Microsoft call buyer realizes 19% same-day gains 04/25/22 Microsoft put buyer realizes 52% same-day gains 03/29/22 Microsoft call buyer realizes 85% same-day gains MAT Mattel $22.14 / -1.055 (-4.55%) 02/17/22 Mattel put volume heavy and directionally bearish HOOD Robinhood $10.00 / -0.405 (-3.89%) 04/12/22 Unusually active option classes on open April 12th 03/30/22 Unusually active option classes on open March 30th 03/30/22 Notable open interest changes for March 30th 03/29/22 Robinhood Markets call volume above normal and directionally bullish HOG Harley-Davidson $36.50 / -1.77 (-4.63%) 03/04/22 Harley Davidson put volume heavy and directionally bearish 03/01/22 Harley Davidson put volume heavy and directionally bearish 02/08/22 Unusually active option classes on open February 8th 02/07/22 Unusually active option classes on open February 7th GOOGL Alphabet Class A $2,377.31 / -84.82 (-3.44%) 04/26/22 Alphabet Class A options imply 6.7% move in share price post-earnings 02/03/22 Unusually active option classes on open February 3rd 02/02/22 Early notable gainers among liquid option names on February 2nd 02/01/22 Alphabet Class A options imply 4.5% move in share price post-earnings BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish BA Boeing $166.91 / -8.84 (-5.03%) 03/21/22 Unusually active option classes on open March 21st 02/14/22 Boeing put buyer realizes 11% same-day gains 01/26/22 Unusually active option classes on open January 26th 12/28/21 Early notable gainers among liquid option names on December 28th
Earnings	Boston Scientific sees FY22 adjusted EPS $1.74-$1.79, consensus $1.77 » 06:36 04/27/22 04/27 06:36 04/27/22 06:36 BSX Boston Scientific $42.63 / -1.955 (-4.38%) Sees FY22 revenue up… Sees FY22 revenue up 7%-9%, consensus $12.84B. The company said, "The company now estimates net sales growth for the full year 2022, versus the prior year period, to be in a range of approximately 7 to 9 percent on a reported basis, and approximately 6.5 to 8.5 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company now estimates EPS on a GAAP basis in a range of $0.78 to $0.88 and estimates adjusted EPS, excluding certain charges (credits), of $1.74 to $1.79." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $42.63 / -1.955 (-4.38%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System 11/01/21 Nevro announces update in Boston Scientific patent litigation, to pay $20M BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Boston Scientific assumed with a Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/27/22 Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open BSX Boston Scientific $42.63 / -1.955 (-4.38%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $42.63 / -1.955 (-4.38%) 02/02/22 Fly Intel: Pre-market Movers 04/27/22 Boston Scientific - BSX 05/05/22 Boston Scientific Corporation 05/19/22 Boston Scientific BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish
Earnings	Boston Scientific sees Q2 adjusted EPS 41c-43c consensus 44c » 06:34 04/27/22 04/27 06:34 04/27/22 06:34 BSX Boston Scientific $42.63 / -1.955 (-4.38%) Sees Q2 revenue up 3%-6%,… Sees Q2 revenue up 3%-6%, consensus $3.27B. The company said, "The company estimates net sales growth for the second quarter of 2022, versus the prior year period, to be in a range of approximately 3 to 6 percent on a reported basis and organic basis. Second quarter organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates EPS on a GAAP basis in a range of $0.19 to $0.23 and adjusted EPS, excluding certain charges (credits), of $0.41 to $0.43." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BSX Boston Scientific $42.63 / -1.955 (-4.38%) 03/16/22 Sight Sciences appoints Brenda Becker to board of directors 02/18/22 FTC approves changes to Boston Scientific divestiture agreement 12/02/21 Boston Scientific initiates trial to evaluate mCRM Modular Therapy System 11/01/21 Nevro announces update in Boston Scientific patent litigation, to pay $20M BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/19/22 Piper Sandler Piper Sandler continues to recommend exposure to medtech space after J&J results 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Boston Scientific assumed with a Buy at Truist 04/06/22 JPMorgan JPMorgan 'tentatively bullish' on medtech, sees two best positioned BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/27/22 Boston Scientific reports Q1 adjusted EPS 39c, consensus 39c 04/26/22 Notable companies reporting before tomorrow's open 02/15/22 Boston Scientific sees 1c of accretion to FY22 adjusted EPS from Baylis deal BSX Boston Scientific $42.63 / -1.955 (-4.38%) 01/04/22 SEC ends investigation into Boston Scientific's heart device, Reuters reports BSX Boston Scientific $42.63 / -1.955 (-4.38%) 02/02/22 Fly Intel: Pre-market Movers 04/27/22 Boston Scientific - BSX 05/05/22 Boston Scientific Corporation 05/19/22 Boston Scientific BSX Boston Scientific $42.63 / -1.955 (-4.38%) 04/14/22 Boston Scientific call volume above normal and directionally bullish 03/18/22 Boston Scientific call volume above normal and directionally bullish 02/23/22 Boston Scientific call volume above normal and directionally bullish 02/18/22 Boston Scientific call volume above normal and directionally bullish

On The Fly

News and insights, exclusive to thefly.com

15:45	#SocialStocks: Jack Dorsey steps down from Twitter board, makes room for Musk»
14:17	Here's what Wall Street experts are saying about Alibaba ahead of earnings»
12:37	What You Missed On Wall Street This Morning»
10:44	Here's what Wall Street experts are saying about Nvidia ahead of earnings»
09:54	Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations»

View all On The Fly Stories »

Upcoming
Events (10)

CEMI	Chembio Diagnostics - CEMI
BWAY ...	MedTech, Tools & Diagnostics Virtual Summit
GOOGL ...	50th Annual Global Technology, Media & Communications Conference
	Macro Financials Thematic Conference
	6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem

ACLS ...	22nd Annual Institutional Investor Conference
	Australasian Emerging Companies Conference
	Frontier Markets Conference
UTRS ...	Global Healthcare Conference

View all of today’s events »

Today’s
Syndicate (1)

KDNY	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial